TELEFLEX INCORPORATED Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
TELEFLEX INCORPORATED (TFX) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of $107.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2026-08-06
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2026-06-30 was $49.00K, a 12.50% decline year-over-year.
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2026-03-31 was $58.00K, a 3.57% increase year-over-year.
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2025-09-28 was $54.00K, a 10.00% decline year-over-year.
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2025-06-29 was $56.00K, a 12.00% increase year-over-year.
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2020 was $146.97M, a 6.37% increase from fiscal 2019.
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2019 was $138.17M, a 83.41% increase from fiscal 2018.
- TELEFLEX INCORPORATED fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2018 was $75.33M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 month |
|---|---|---|---|---|
| 2026-06-30 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $107.00K 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | $58.00K 10-Q · filed 2026-05-07 | |||
| 2025-09-28 | $54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $110.00K derived: sum of 2 quarters · filed 2025-11-06 | $166.00K 10-Q · filed 2025-11-06 | |
| 2025-06-29 | $56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $112.00K 10-Q · filed 2025-07-31 | ||
| 2025-03-30 | $56.00K 10-Q · filed 2025-05-01 | |||
| 2024-09-29 | $60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $110.00K derived: sum of 2 quarters · filed 2024-10-31 | $182.00K 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $122.00K 10-Q · filed 2024-08-02 | ||
| 2024-03-31 | $72.00K 10-Q · filed 2024-05-03 | |||
| 2023-10-01 | $1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $1.17M derived: sum of 2 quarters · filed 2023-11-03 | $1.24M 10-Q · filed 2023-11-03 | |
| 2023-07-02 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $121.00K 10-Q · filed 2023-08-03 | ||
| 2023-04-02 | $64.00K 10-Q · filed 2023-05-04 | |||
| 2021-09-26 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $18.49M derived: sum of 2 quarters · filed 2021-10-28 | $31.56M 10-Q · filed 2021-10-28 | |
| 2021-06-27 | $17.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $30.49M 10-Q · filed 2021-07-29 | ||
| 2021-03-28 | $13.07M 10-Q · filed 2021-04-29 | |||
| 2020-12-31 | $146.97M 10-K · filed 2021-02-25 | |||
| 2020-06-28 | $66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $140.72M 10-Q · filed 2020-07-30 | $140.79M derived: sum of 3 quarters · filed 2021-02-25 | $140.87M derived: sum of 4 quarters · filed 2021-02-25 |
| 2020-03-29 | $140.65M 10-Q · filed 2020-04-30 | $140.72M derived: sum of 2 quarters · filed 2021-02-25 | $140.80M derived: sum of 3 quarters · filed 2021-02-25 | $141.94M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-12-31 | $73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $151.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.28M derived: sum of 3 quarters · filed 2021-02-25 | $138.17M 10-K · filed 2021-02-25 |
| 2019-09-29 | $78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $1.21M derived: sum of 2 quarters · filed 2019-10-31 | $138.10M 10-Q · filed 2019-10-31 | $138.18M derived: sum of 4 quarters · filed 2020-02-21 |
| 2019-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $138.02M 10-Q · filed 2019-08-01 | $138.10M derived: sum of 3 quarters · filed 2020-02-21 | $148.98M derived: sum of 4 quarters · filed 2020-02-21 |
| 2019-03-31 | $136.89M 10-Q · filed 2019-05-02 | $136.97M derived: sum of 2 quarters · filed 2020-02-21 | $147.85M derived: sum of 3 quarters · filed 2020-02-21 | $212.13M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $10.96M derived: sum of 2 quarters · filed 2020-02-21 | $75.24M derived: sum of 3 quarters · filed 2020-02-21 | $75.33M 10-K · filed 2020-02-21 |
| 2018-09-30 | $10.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $75.16M derived: sum of 2 quarters · filed 2018-11-01 | $75.25M 10-Q · filed 2018-11-01 | |
| 2018-07-01 | $64.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $64.37M 10-Q · filed 2018-08-02 | ||
| 2018-04-01 | $91.00K 10-Q · filed 2018-05-03 | |||
| 2017-10-01 | $92.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $166.00K derived: sum of 2 quarters · filed 2017-11-02 | $245.00K 10-Q · filed 2017-11-02 | |
| 2017-07-02 | $74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $153.00K 10-Q · filed 2017-08-03 | ||
| 2017-04-02 | $79.00K 10-Q · filed 2017-05-04 | |||
| 2016-09-25 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-27 | $72.00K derived: sum of 2 quarters · filed 2016-10-27 | $133.00K 10-Q · filed 2016-10-27 | |
| 2016-06-26 | $72.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $133.00K 10-Q · filed 2016-07-28 | ||
| 2016-03-27 | $61.00K 10-Q · filed 2016-04-28 | |||
| 2015-09-27 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $4.00M derived: sum of 2 quarters · filed 2015-10-29 | $8.00M 10-Q · filed 2015-10-29 | |
| 2015-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $4.00M 10-Q · filed 2015-07-30 | ||
| 2015-03-29 | $4.00M 10-Q · filed 2015-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |